My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 150

    2.
    3.

    Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis.

    Ramaiah KD, Vijay Kumar KN, Ravi R, Das PK.

    Ann Trop Med Parasitol. 2005 Apr;99(3):243-52.PMID: 15829134 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India.

    Ramaiah KD, Vijay Kumar KN, Chandrakala AV, Augustin DJ, Appavoo NC, Das PK.

    Trop Med Int Health. 2001 Dec;6(12):1062-9.PMID: 11737843 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage.

    Ramaiah KD, Vijay Kumar KN, Hosein E, Krishnamoorthy P, Augustin DJ, Snehalatha KS, Nanda B, Das PK.

    Ann Trop Med Parasitol. 2006 Jun;100(4):345-61.PMID: 16762115 [PubMed - indexed for MEDLINE]Related articles

    6.

    Elimination of lymphatic filariasis in India--a successful endeavour.

    Srivastava PK, Dhillon GP.

    J Indian Med Assoc. 2008 Oct;106(10):673-4, 676-7.PMID: 19552103 [PubMed - indexed for MEDLINE]Related articles

    7.

    A rapid method to assess the coverage of the mass drug administration of diethylcarbamazine in the program to eliminate lymphatic filariasis in India.

    Babu BV.

    Southeast Asian J Trop Med Public Health. 2005 Jan;36(1):44-5.PMID: 15906640 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.

    Vanamail P, Ramaiah KD, Subramanian S, Pani SP, Yuvaraj J, Das PK.

    Ann Trop Med Parasitol. 2005 Apr;99(3):237-42.PMID: 15829133 [PubMed - indexed for MEDLINE]Related articles

    9.

    A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects.

    Ramaiah KD, Das PK, Appavoo NC, Ramu K, Augustin DJ, Kumar KN, Chandrakala AV.

    Trop Med Int Health. 2000 Dec;5(12):842-7.PMID: 11169272 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?]

    Chanteau S, Roux JF.

    Bull Soc Pathol Exot. 2008 Jun;101(3):254-60. French. PMID: 18681220 [PubMed - indexed for MEDLINE]Related articles

    11.

    An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of gujarat.

    Kumar P, Prajapati P, Saxena D, Kavishwar AB, Kurian G.

    Indian J Community Med. 2008 Jan;33(1):38-42.PMID: 19966995 [PubMed - in process]Related articlesFree article

    13.

    Participation in three consecutive mass drug administrations in Leogane, Haiti.

    Mathieu E, Direny AN, de Rochars MB, Streit TG, Addiss DG, Lammie PJ.

    Trop Med Int Health. 2006 Jun;11(6):862-8.PMID: 16772008 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India.

    Kerketta AS, Babu BV.

    Asia Pac J Public Health. 2009 Jan;21(1):112-7.PMID: 19124342 [PubMed - indexed for MEDLINE]Related articles

    15.

    Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis.

    Babu BV, Behera DK, Kerketta AS, Mishra S, Rath K, Swain BK, Mishra S, Kar SK.

    Ann Trop Med Parasitol. 2006 Oct;100(7):621-30.PMID: 16989688 [PubMed - indexed for MEDLINE]Related articles

    16.
    17.

    Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka.

    Weerasooriya MV, Yahathugoda CT, Wickramasinghe D, Gunawardena KN, Dharmadasa RA, Vidanapathirana KK, Weerasekara SH, Samarawickrema WA.

    Filaria J. 2007 Nov 15;6:11.PMID: 18005398 [PubMed]Related articlesFree article

    19.
    20.

    Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries.

    Huppatz C, Capuano C, Palmer K, Kelly PM, Durrheim DN.

    BMC Infect Dis. 2009 Jun 12;9:92.PMID: 19523192 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk